Nicolas Dauby
Nicolas Dauby is an expert in Infectiology at Centre Hospitalier Universitaire de Saint-Pierre (Belgium). As of October 2026, ScienceLeadR ranks Nicolas Dauby in the top 1% of experts worldwide for Pneumonia, Coronavirus Infections and COVID-19. Nicolas Dauby has authored 183 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 2 of them ongoing. SLR score: 770 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Immunology - Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 183
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| High proportion of pregnant women and migrants among adults hospitalised with varicella in Belgium 2012-2022: a case series study. PMID 42891980 — pregnant women, pregnancy, vaccines, chickenpox, vaccination, pneumonia, communicable diseases, child | Infect Dis (Lond) | 2026 | 0 |
| Characteristics and outcomes of adult patients hospitalised with RSV infection, influenza or COVID-19 in Belgium, winter seasons 2023/24 and 2024/25. PMID 42757413 — comorbidity, mortality, vaccines, hospital mortality, vaccination, covid-19, influenza, human, communicable diseases, infections, respiratory syncytial virus infections | Euro Surveill | 2026 | 0 |
| Maternal respiratory syncytial virus vaccination for infant protection: updated systematic review and meta-analysis of efficacy, effectiveness, and safety. PMID 42699312 — respiratory syncytial viruses, mortality, safety, vaccines, vaccination, viruses, infant, vaccine efficacy | New Microbes New Infect | 2026 | 0 |
| Acute kidney injury among hospitalized people living with HIV. PMID 42637702 — kidney diseases, sexually transmitted diseases, mortality, hospitalization, hospital mortality, recycling, kidney, acquired immunodeficiency syndrome, therapeutics, renal replacement therapy, acute kidney injury | Int J STD AIDS | 2026 | 0 |
| Randomized clinical trials of COVID-19 vaccines are not designed to study non-specific effects on rare mortality. PMID 42491622 — mortality, vaccines, covid-19 vaccines, covid-19 | iScience | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachment inhibitor to an integrase inhibitor based antiretroviral therapy regimen in adults living with HIV (ENTRANCE) 2025-520629-19-00 — broadly neutralizing antibodies, antibodies, neutralizing, hiv, integrase inhibitors, therapeutics, integrases | Phase 1 | Active not recruiting | 2025 |
| Vaccination Against COVID 19 in Pregnant and Lactating Women in Belgium NCT05618548 — milk, human, pregnancy, sars-cov-2, milk, safety, vaccines, covid-19 vaccines, antibodies, cohort studies, viral vaccines, rna, messenger, vaccination, covid-19, breast, immunity, severe acute respiratory syndrome-related coronavirus, women | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map